Dramatic increase in hepatic and biliary curcumin exposure by modulation of its elimination pathway in rats

作者：Lee Joo Hyun^*; Kim Han Gyul; Oh Ju Hee; Lee Young Joo

来源：Journal of Pharmacy and Pharmacology, 2013, 65(3): 423-429.

DOI：10.1111/j.2042-7158.2012.01610.x

• biliary excretion
• cancer
• curcumin
• metabolism
• probenecid

Objectives Curcumin, a major component of the food spice turmeric (Curcuma longa), has multiple beneficial effects on diseases of the liver and bile duct. We have investigated whether modulation of the curcumin elimination pathway could increase its hepatic and biliary exposure in rats. Methods Probenecid, an inhibitor of the metabolism and biliary excretion of curcumin, was used as a modulator. After intravenous administration of curcumin at a dose of 18?mg/kg/h without (control) or with co-infusion of probenecid (230?mg/kg/h) in rats, the pharmacokinetic parameters of curcumin were estimated. Key findings Coadministration of probenecid significantly increased the total area under the plasma (1.88-fold) and bile (6.73-fold) concentrationtime curves from 0 to 80?min of curcumin relative to those in the controls. The tissue-to-plasma concentration ratio in the liver was also dramatically increased (69.3-fold) by probenecid. These results may be attributed to the dual inhibitory effects of probenecid, to a greater extent, on metabolism via glucuronidation, and to a lesser extent, on the biliary excretion of curcumin via the multidrug resistance-associated protein 2. Conclusions The probenecid-mediated increase in hepatic and biliary exposure of curcumin suggested that the use of combination drug regimens involving curcumin and modulators of elimination may be an innovative approach for the therapeutic use of curcumin.

• 出版日期2013-3